Related Experiment Video

Updated: May 4, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

6.5K

Cancer subclonal genetic architecture as a key to personalized medicine

Alnawaz Rehemtulla1

  • 1Departments of Radiation Oncology and Radiology, University of Michigan, Ann Arbor, MI.

Neoplasia (New York, N.Y.)
|January 10, 2014
PubMed

Insights

Personalized cancer therapy requires identifying tumor mutations for targeted treatments. Understanding tumor genetic diversity is crucial for effective, evidence-based oncology and selecting the best treatment options.

Area of Science:

  • Oncology
  • Genetics
  • Evidence-Based Medicine

Background:

  • Personalized oncological therapy relies on evidence-based medicine.
  • Identifying specific mutations is crucial for targeted therapy regimens.
  • Intratumoral genetic diversity impacts biopsy-based prognosis.

Purpose of the Study:

  • To highlight the importance of molecular subtyping in cancer treatment planning.
  • To emphasize the role of intraclonal genetic diversity in prognosis.
  • To underscore the need for understanding clonal architecture in selecting efficacious therapies.

Main Methods:

  • Review of current evidence-based medicine principles in oncology.
  • Analysis of the implications of molecular subtyping.
  • Investigation into the significance of intraclonal genetic diversity.
  • Exploration of clonal architecture in cancer progression.

Main Results:

  • Molecular subtyping is vital for treatment planning.
  • Intraclonal genetic diversity significantly affects prognosis.
  • Delineating clonal architecture is key to treatment selection.

Conclusions:

  • Evidence-based medicine integrating all available data is essential for personalized oncology.
  • Understanding tumor genetics, including diversity and clonal architecture, is imperative for selecting optimal targeted therapies.
  • Further research into clonal architecture will refine prognostic accuracy and therapeutic strategies.

More Related Videos

Comparative Lesions Analysis Through a Targeted Sequencing Approach08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.2K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

26.1K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

1.5K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.7K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.6K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

3.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K